Bioinformatics for Molecular Docking & Drug Discovery Webinar Hosted Efficiently
Date- 18/03/2025
Metropolis- Bengaluru
State – Karnataka, India
Bangalore, India – On March 18, 2025, Biotecnika efficiently performed an insightful 60-minute reside webinar on “Bioinformatics for Molecular Docking & Drug Discovery: Prime Computational Instruments & Strategies” on YouTube. The webinar attracted a broad viewers of researchers, biotech professionals, college students, and trade specialists wanting to study in regards to the position of bioinformatics and computational instruments in accelerating drug discovery.
With the rising adoption of Laptop-Aided Drug Design (CADD) in pharmaceutical and biotech analysis, the session supplied members with complete information of molecular docking, important computational instruments, and real-world functions of AI/ML in drug improvement.
Webinar Overview
The occasion started with a gap tackle by the host, who emphasised the rising significance of computational drug discovery and launched the esteemed panel of audio system. Every professional delivered a centered 15-minute session overlaying basic rules, software demonstrations, and cutting-edge developments within the subject.
Key Audio system from the Webinar
Dr. Prodyot Banerjee – Molecular Docking & Simulations in Drug Discovery
Dr. Banerjee supplied a complete introduction to molecular docking rules, explaining the lock-and-key mannequin, scoring features, and the position of ligand flexibility in inaccurate drug design
. He mentioned how bioinformatics is revolutionizing digital screening and goal identification, enabling researchers to foretell drug-target interactions with larger precision. He additionally addressed widespread challenges in computational drug design, such because the accuracy-speed tradeoff and the necessity for enhanced ligand flexibility fashions.
Dr. Nilofer – Key Computational Instruments & Strategies Dr. Nilofer’s session was a sensible deep dive into broadly used computational instruments for molecular docking and molecular dynamics simulations. She demonstrated:
1.AutoDock & SwissDock/PyRx – Workflow for establishing docking experiments
2.PyMOL & Discovery Studio – Visualization of protein-ligand interactions
3. GROMACS & Desmond – Molecular dynamics simulations for post-docking validation
She additionally supplied steering on software choice, discussing some great benefits of open-source vs. industrial software program and the significance of scalability for high-throughput screening.
Dr. Abhishek Aher – Superior Functions & Case Research
As an invited professional from CCMB, Hyderabad, Dr. Aher offered real-world case research the place molecular docking was pivotal in drug discovery success tales. He mentioned the invention of HIV protease inhibitors utilizing docking simulations and the way AI and machine studying are built-in into drug analysis by means of instruments like AlphaFold and deep studying fashions for binding affinity predictions.
Moreover, he supplied a forward-looking perspective on rising tendencies in computational drug discovery, together with:
1. The potential of quantum computing in drug design
2. The rise of polypharmacology and multi-target drug discovery
3. How AI-driven approaches are enhancing molecular docking accuracy
Interactive Q&A & Key Takeaways
The webinar concluded with a dynamic Q&A session, the place attendees engaged with the audio system, looking for extra profound insights into the functions and challenges of bioinformatics in drug discovery.
Key Takeaways from the Webinar:
- Molecular docking is a essential software for accelerating early-stage drug discovery.
- Bioinformatics instruments like AutoDock, PyRx, and GROMACS simplify and improve drug screening workflows.
- AI & ML are revolutionizing molecular docking by enhancing binding affinity predictions and streamlining drug design.
- The way forward for computational drug discovery is shifting in direction of quantum computing and multi-target drug design.
Knowledgeable speaker:
Dr. Abhishek Aher is a Venture Scientist on the Centre for Mobile & Molecular Biology (CCMB), Hyderabad, India. He accomplished his Ph.D. in anti-cancer analysis on the Centre for DNA Fingerprinting & Diagnostics (CDFD) in 2023, adopted by postdoctoral analysis in immunology at CDFD. With over a decade of analysis expertise, Dr. Aher has made notable contributions to most cancers drug discovery and neurodegenerative illness analysis.
His experience spans drug discovery and improvement for most cancers and Parkinson’s, specializing in therapeutic screening, protein aggregation issues, and molecular concentrating on. He has printed 10 peer-reviewed analysis papers in prestigious journals and has been acknowledged with a number of awards for his scientific achievements.
Presently, he’s concerned in growing small-molecule therapeutics for Lewy physique dementia, contributing to developments in neurodegenerative illness therapy.
About Biotecnika:
Biotecnika is India’s main biosciences platform, empowering over 4.5 million subscribers globally with training, profession steering, and trade insights. With over 18 years of expertise connecting biotech professionals with profession alternatives, Biotecnika stays dedicated to fostering innovation and progress within the life sciences sector.
A Resounding Success!
The webinar acquired an amazing response, with attendees praising the readability, depth, and sensible insights shared by the specialists. Many members expressed enthusiasm for future periods on AI/ML in drug discovery, in-depth computational methods, and hands-on coaching in bioinformatics instruments.
Biotecnika thanks the esteemed audio system and attendees for making this occasion a hit. The group stays dedicated to delivering cutting-edge information in biotech, bioinformatics, and drug discovery by means of extra such initiatives.
For many who missed the reside session on Bioinformatics for Molecular Docking & Drug Discovey, the recording is now accessible on Biotecnika’s YouTube channel.
